Hyderabad Telangana, India

Satyanarayana Revu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2011-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Satyanarayana Revu: Innovator in Pharmaceutical Patents

Introduction

Satyanarayana Revu is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds and their crystalline forms. With a total of 2 patents to his name, his work has implications for drug formulation and delivery.

Latest Patents

Revu's latest patents include innovative formulations such as the polymorphs of 7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]-amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide and its pharmaceutically acceptable salts. This invention relates to novel crystalline forms and processes for their preparation. Additionally, he has developed crystalline polymorphic forms of vardenafil and vardenafil hydrochloride, along with processes for preparing them.

Career Highlights

Throughout his career, Satyanarayana Revu has worked with prominent companies in the pharmaceutical industry. He has been associated with Dr. Reddy's Laboratories and MSN Laboratories Private Limited, where he contributed to research and development efforts. His work has been instrumental in advancing pharmaceutical formulations and improving drug efficacy.

Collaborations

Revu has collaborated with several professionals in his field, including Eswaraiah Sajja and Ravindar Reddy Koppera. These collaborations have fostered innovation and have led to the successful development of new pharmaceutical products.

Conclusion

Satyanarayana Revu's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an innovator. His work continues to influence the development of effective drug formulations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…